Company Snapshot o Neuro Tech Solutions Ltd NTS

Company Snapshot o Neuro. Tech Solutions Ltd (NTS) is a leading provider of innovative cloudbased software technologies focused on assessment, monitoring and improvement of human cognition and behavior, with a particular emphasis on attention. o Established Market Presence for ADHD product: MOXO Continuous Performance Test o o o 2 EU, Americas, Asia, S. Africa CE approved National/Regional distributors Installed Base: 400 centers, 88, 000+ tests since launch >20% sales growth y-y Additional new markets in process o Dynamic development and clinical research portfolio

ADHD Market Drivers o 24/7 connectivity, urbanization o Increased awareness, rising social expectations o Shifting diagnostic guidelines UK Potential Market o According to NICE guidance 1, the prevalence of ADHD is 5% of school-aged children. Also according to NICE, o ADHD is currently underdiagnosed in the UK. o 1% of school-aged children meet the diagnostic criteria for severe combined type ADHD and should receive treatment (this equates to approximately 100, 000 children in the UK). However only 70, 000 children are currently receiving medication for their ADHD. o Over half (54%) of the child and adolescent psychiatrists and community pediatricians recently surveyed also stated that ADHD is currently underdiagnosed in the UK

UK Survey Findings : the potential impact of undiagnosed and untreated ADHD 3 o ADHD was rated as having as great an impact on a child’s development as depression, Tourette’s Syndrome, anxiety or dyslexia. 80% of specialists surveyed rated ADHD as having the greatest or second greatest impact of these conditions on a child’s development o 98% of those surveyed believed undiagnosed ADHD has a serious impact on a child’s academic progress and they are more likely to drop out of school several years earlier than their peers o Over 90% said that undiagnosed and untreated ADHD: o Has a serious impact on a child’s relationships with their parents, siblings and peers o Can result in children feeling excluded from their peers, impacting their ability to make friends and leading to very low self-esteem due to their exclusion o Can lead to a variety of social problems, such as difficulties finding and keeping a job and criminal behavior (such as stealing, shoplifting and vandalism) 4

ADHD Assessment Tools o DSM-IV or ICD-10 o Questionnaires completed by the specialist, parents and teachers e. g. Conners Teacher and Parent o Rating Scales o Tests which measure the length and type of mental process (psychometric tests and profiles) o Tests of attention and persistence e. g. Continuous Performance Test (CPT) 5

Challenging diagnostic environment: ADHD symptoms overlap with those of other disorders Other psychiatric/ behavioral disorder ADHD with Comorbidity “Pure” Attention Disorder Stimulant Addiction/ Enhancement Diagnosis of ADHD can be difficult because other problems (such as autism, Asperger’s Syndrome, epilepsy, depression, brain injury or family dysfunction) can result in behavior similar to ADHD. 6

Unmet need: easily-deployed, cost-effective, objective tool to support clinical diagnosis and research Next Generation Solution: MOXO d-CPT Test 7

Accessible QBtest Expensive IVA+ T. O. V. A Conners CPT III GDS Quotient AULA NEBA 8 Limited Affordable

Low Overhead • Cloud-based, no specialized HW Patient-Centric • Accessible from anywhere Objective • Automated, immediate results • Contemporary reference group collected across four continents Innovative • Novel multimodal distractor- approach simulates real-life, sensory and emotional features Universal • No language/number confounds • Pediatric and teen/adult versions Secure • HIPAA and EU privacy compliant 9 MOXO: Streamlined, Effective Assessment of Attention

Demonstration of MOXO Stimuli – Pediatric Version Click o n grap hi view c to demo nstrat ion 10

Demonstration of MOXO Stimuli – Teens/Adults Version

Test Results Reports Patient Profile o Comparison of individual performance to norm group. o o o Norm criteria: age and gender Indices: Attention, Timing, Hyperactivity and Impulsiveness Scoring: Calculated for each index and categorized by performance level o Includes severity measure for aberrant scores Performance Graph o Maps performance throughout the test o o Example: impulsivity change due to major visual distractors o Baseline Major/Minor auditory Major/Minor visual Combined Provides distractor impact by index

Market Segments A diagnosis of ADHD should only be made by a specialist psychiatrist, pediatrician or other appropriately qualified healthcare professional with training and expertise in the diagnosis of ADHD (NICE Guidelines) Additional Verticals: Universities, HR agencies, Driver Examination Centers, … 13

MOXO: Supporting Eco-System School system MOXO Professi -onals 16 Health System

Key Scientific Advisors Edmund Sonuga-Barke, Ph. D Member, World Health Org. workgroup on Future of Psychiatric Diagnosis Itai Berger, MD Director, Pediatric Neurology Unit and Neuro-Cognitive Center, Hadassah University Hospital David Coghill, MD Reader in Child and Adolescent Psychiatry, University of Dundee, UK Visiting Professor of Child and Adolescent Psychiatry, Ning-Bo University, China

MOXO: business opportunity o Need: Need Growing demand for ADHD diagnosis o The MOXO Solution: Solution objective, accurate, based on modern norms o Significant market presence: presence Turkey, Poland, S. Africa, Mexico, Spain, Israel and additional markets underway o Market acceptance: acceptance consistently used by hospitals, universities, large clinics around the globe o ROI: ROI low overhead, streamlined cloud-base service o Clinician-centric tools: tools coherent results report, developmental report, comparative report (for longitude monitoring), large data base analytics, GCP compliant clinical system 18

www. neurotech-solutions. com I www. moxo-adhdtest. com